Vas Narasimhan
Vas Narasimhan is the Chief Executive Officer of Novartis, a leading global healthcare company. Under his leadership, he has focused on advancing innovative therapies while addressing challenges in healthcare costs and access. Narasimhan advocates for sustainable practices in the pharmaceutical industry, emphasizing the need for ethical pricing of medications to ensure that life-saving treatments are accessible to all patients.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 2 | 6.00 | 0.33% | +10% | 8,654,622 | 31,628 | $700,000 | 2,558$ |
| Totals | 2 | 8,654,622 | 31,628 | $700,000 | 2,558$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Vas Narasimhan is the CEO of Novartis and participated in the announcement of the drug pricing deal with the US government.
7
Switzerland:
Vas Narasimhan is the CEO of Novartis and is married to Srishti Gupta.
5
Switzerland:
Novartis-CEO Vas Narasimhan received 25 million francs last year.
7
Switzerland:
Vas Narasimhan, CEO of Novartis, attended the announcement of a deal with the U.S. government to lower drug prices.
6
Switzerland:
Vas Narasimhan, the CEO of Novartis, earned nearly 25 million francs in 2025, sparking public outrage over his salary.
4
Switzerland:
Vas Narasimhan has been leading the Swiss pharmaceutical company Novartis for eight years and is focused on further expansion.
8
Switzerland:
Vas Narasimhan is the CEO of Novartis and was involved in discussions regarding drug pricing with the U.S. government.
6
Switzerland:
Vas Narasimhan, CEO of Novartis, received high marks for his functional reputation among Swiss CEOs.
7
Switzerland:
Vas Narasimhan, CEO of Novartis, attended the announcement at the White House.
7
Switzerland:
Vas Narasimhan, the CEO of Novartis, is involved in discussions about drug pricing strategies.
6